Evidence map›Paper›PMID 40720453›Full record

ArticlePloS one2025

Primary prevention cardiovascular disease risk prediction model for contemporary Chinese (1°P-CARDIAC): Model derivation and validation using a hybrid statistical and machine-learning approach.

Yekai Zhou, Celia Jiaxi Lin, Qiuyan Yu, Joseph Edgar Blais, Eric Yuk Fai Wan, Emmanuel Wong, Kathryn Tan, David Chung-Wah Siu, Kai Hang Yiu, Esther Wai Yin Chan and 6 more

Abstract readValidation Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yekai ZhouSchool of Computing and Data Science, The University of Hong Kong, Hong Kong Special Administration Region, China.
Celia Jiaxi LinSchool of Nursing, The University of Hong Kong, Hong Kong Special Administration Region, China.
Qiuyan YuLaboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administration Region, China.
Joseph Edgar BlaisCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region, China.ORCID https://orcid.org/0000-0001-7895-198X
Eric Yuk Fai WanCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region, China.
Emmanuel WongDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administration Region, China.ORCID https://orcid.org/0000-0001-5205-9440
Kathryn TanDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administration Region, China.
David Chung-Wah SiuDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administration Region, China.
Kai Hang YiuDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administration Region, China.
Esther Wai Yin ChanLaboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administration Region, China.
Doris YuSchool of Nursing, The University of Hong Kong, Hong Kong Special Administration Region, China.
William WongDepartment of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administration Region, China.
Tak-Wah LamSchool of Computing and Data Science, The University of Hong Kong, Hong Kong Special Administration Region, China.
Ian Chi Kei WongLaboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administration Region, China.
Ruibang LuoSchool of Computing and Data Science, The University of Hong Kong, Hong Kong Special Administration Region, China.
Celine S L ChuiLaboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administration Region, China.ORCID https://orcid.org/0000-0003-1513-8726

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease (CVD) is the leading cause of mortality and morbidity in China and worldwide while we are lacking in validated primary prevention model specifically for Chinese. To identify CVD high-risk individuals for early intervention, we created and validated a primary prevention risk prediction model, Personalized CARdiovascular DIsease risk Assessment for Chinese (1°P-CARDIAC), in contemporary Chinese cohorts in Hong Kong.

methodsPatients without any history of CVD was categorized as derivation and validation cohorts based on their different geographical location of residence in Hong Kong. The outcome was the first diagnosis of a composite of coronary heart disease, ischemic or hemorrhagic stroke, peripheral artery disease, and revascularization. The full model incorporated all available variables in the dataset as clinical laboratory tests, disease and medication history, family history of disease, demographic factors, and healthcare utilization. We employed XGBoost Cox model and multivariate imputation with chained equation (MICE) for derivation and missing data replacement. A basic model was developed with the integration of statistically significant and important subset of risk variables by least absolute shrinkage and selection operator (LASSO) regression. Validation was performed by 1000 bootstrap replicates and compared to four existing models: PREDICT, pooled cohort equation (PCE), China-PAR, and Framingham (Asian).

resultsThe study included 179,953 patients in the derivation cohort and 1,083,924 patients across two independent validation cohorts. A total of 103 covariates were included in the full model whilst 8 covariates were included the basic model. It demonstrated good performance with C-statistic of 0.87 (95% CI: 0.87, 0.87), calibration slope of 0.94 in the full model. The C-statistic in the basic model was 0.75 (95% CI: 0.75, 0.75) with calibration slope of 0.91. Other comparison risk models have lower C statistic ranging from 0.68 to 0.72.

conclusionWe developed and validated 1°P-CARDIAC, a CVD risk prediction model for primary prevention applying a novel hybrid statistical and machine-learning approach. Validation results suggest that it may offer improved performance compared to commonly used risk models. The 1°P-CARDIAC yields the similar level of accuracy and performance between basic and full model. It demonstrated both effectiveness and versatility in harnessing the power of big data and which has the potential to serve as a promising method for CVD primary prevention and improving public health outcome.

Indexed as

Cardiovascular DiseasesMachine LearningModels, StatisticalPrimary PreventionAgedEast Asian PeopleFemaleHong KongHumansMaleMiddle AgedRisk AssessmentRisk Factors

Identifiers

PMID40720453
PMCPMC12303301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.